肝癌介入治疗的现状及评价

• 作 者: 吴伯文 徐爱民 潘泽亚
• 机 构: 第二军医大学东方肝胆外科医院,第二军医大学东方肝胆外科医院,第二军医大学东方肝胆外科医院 上海200438,上海200438,上海200438
• 出 处: 中国实用外科杂志
• 发表日期: 2003年12期
• 关键词: 肝癌介入治疗 手术切除 疗效 临床 原发性肝癌 术后复发率 根治性切除 肝功能异常 非手术治疗 非手术疗法 综合疗法 显著成效 介入疗法 肝内播散 肝癌病人 恶

原发性肝癌 (下称肝癌 )是我国高发病率的恶性肿瘤之一 ,近年我国对肝癌的治疗取得了显著成效 ,特别是手术切除的疗效有了显著提高 ,2 0世纪 90年代后肝癌总的术后 5年生存率达 48 6% ,其中小肝癌达 73 3 % [1 ] 。但由于多数肝癌的发现均较晚或早期即有肝内播散 ;肝癌病人多

Primary liver cancer (hereinafter referred to as liver cancer) is one of the high-incidence malignancies in China. In recent years, remarkable progress has been made in the treatment of liver cancer in China. In particular, the curative effect of surgical resection has been significantly improved. After the 1990s, the total amount of liver cancer was The 5-year survival rate after surgery was 48 6%, of which 73.7% were small hepatocellular carcinoma [1]. However, because most liver cancers are found later or early in the day, they are spread in the liver;